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Objective: In patients with advanced kidney disease, metabolic and nutritional derangements induced by uremia interact and rein-
force each other in a deleterious vicious circle. Literature addressing the effect of dialysis initiation on changes in body composition
(BC) is limited and contradictory. The aim of this study was to evaluate changes in BC in a large international cohort of incident hemo-
dialysis patients.
Methods:A total of 8,227 incident adult end-stage renal disease patients with BC evaluationwithin the initial first 6months of baseline,
defined as 6months after renal replacement therapy initiation, were considered. BC, including fat tissue index (FTI) and lean tissue index
(LTI), were evaluated by Body CompositionMonitor (BCM, FreseniusMedical Care, BadHomburg, Germany). Exclusion criteria at base-
line were lack of a BCM measurement before or after baseline, body mass index (BMI) , 18.5 kg/m2, presence of metastatic solid tu-
mors, treatment with a catheter, and prescription of less or more than 3 treatments per week. Maximum follow-up was 2 years.
Descriptive analysis was performed comparing current values with the baseline in each interval (delta analysis). Linear mixed models
considering the correlation structure of the repeated measurements were used to evaluate factors associated with different trends in
FTI and LTI.
Results: BMI increased about 0.6 kg/m2 over 24 months from baseline. This was associated with increase in FTI of about 0.95 kg/m2
and a decrease in LTI of about 0.4 kg/m2. Female gender, diabetic status, and low baseline FTI were associated with a significant greater
increase of FTI. Age. 67 years, diabetes, male gender, high baseline LTI, and low baseline FTI were associatedwith a significant greater
decrease of LTI.
Conclusions:With the transition to hemodialysis, end-stage renal disease patients presented with distinctive changes in BC. These
weremainly associated with gender, older age, presence of diabetes, low baseline FTI, and high baseline LTI. BMI increases did not fully
represent the changes in BC.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Editorial, p. 63
Introduction
THE PREVALENCE OF protein-energy wasting isvery high in dialysis patients1 because of the synergic
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72contribution of decreased protein and/or energy intake,
chronic inflammation, physical inactivity, concurrent acute
or chronic conditions or illness, and catabolism induced by
hemodialysis process.2 On the basis of the repetitive and
prolonged nature of these processes, a deterioration of the
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Figure 1. Study design. Hypothetical BCM measurement
times are indicated with ‘‘x’’ as Body Composition Monitor
(BCM) measurements were not done at strictly regular
intervals. Body composition measurement was conducted
with the BCM (FMC, Bad Homburg, Germany). RRT, renal
replacement therapy.
BODY COMPOSITION CHANGES IN INCIDENT DIALYSIS PATIENTS 73However, the initiation of hemodialysis might also
improve nutritional state, for example, by improving appe-
tite due to the partial reversal of the uremic state and correc-
tion ofmetabolic acidosis. Pupim et al.3 in 2002 showed that
the initiation of hemodialysis was associatedwith significant
improvement of most nutritional markers, including
albumin, prealbumin, dietary protein intake derived from
nitrogen appearance rate, and body composition (BC)
such as fat mass (1.296 2.20 kg). Vendrely et al.,4 in a study
evaluating the fat and lean body mass development during
the first year on hemodialysis in 15 patients previously
treated with supplemented very low–protein diet and 15
patients on less restricted diet, found a significant increase
in fat mass (12.66 18.7% and 16.66 16.1%, respectively).
Leanmass remained stable overall in the 2 groups of patients.
On the other hand, other studies showed that lean body
mass significantly decreased after 24 months.3,5 The
increase in albumin and creatinine levels during the first
6 months of hemodialysis also reported by Goldwasser
et al.6 can be explained by the decline of renal function
and the progressive retention of proteins and creatinine. A
study by Raffaitin et al.7 on a group of 10 diabetic patients
starting dialysis and monitored by means of dual X-ray
absorptiometry (DXA) confirmed a significant decrease in
lean tissue mass and serum albumin over a period of 2 years.
A more recent study from Mathew et al.,8 evaluating 41
prevalent hemodialysis or peritoneal dialysis patients sur-
viving 24 months after their baseline anthropometric eval-
uation, showed a significant increase in triceps and biceps
skin fold thicknesses and mid-arm circumference. Finally,
Kalantar–Zadeh et al.9 evaluated the body fat in 535 prev-
alent hemodialysis patients by near infrared interactance.
After 6 months, they found that the 411 patients still on
follow-up were stratified as follows: 27.5% with significant
fat loss and 29.9%with significant fat gain. Similarly, Johan-
sen et al.,10 evaluating 54 prevalent hemodialysis patients
with 4 measurements of fat mass and lean mass by DXA
over a year, did not find any significant trend.
In summary, the number of studies evaluating changes in
nutritional parameters after the initiation of dialysis is
limited and largely based on longitudinal studies in preva-
lent patients, often with contradictory results. This obser-
vational study in a large cohort of incident hemodialysis
patients regularly monitored with bioimpedance spectros-
copy aims to assess changes in BC in the initial phase of renal
replacement therapy (RRT).
Methods
The study population was extracted from a database of
49,846 patients on hemodialysis treatment in 417 Nephro-
Care centers throughout 21 countries in Europe, Latin
America, and South Africa between January 1, 2007 and
January 1, 2014. Patients were included if they were no
longer than 6 months on RRT before admission to the
unit (incident patients only) and if they underwent evalua-tion of BC using the Body Composition Monitor (BCM;
Fresenius Medical Care (FMC), Germany). Baseline was
defined as 6 months after hemodialysis initiation. Baseline
values were defined as the mean of all measurements in
the last 5 months before baseline (baseline period, Fig. 1).
Patients were followed for a maximum of 2 years. Patients
without at least 1 BCMmeasurement before and after base-
line (defined as 6 months after RRT initiation) were
excluded. To focus on a homogenous well-treated hemodi-
alysis population and avoid including patients already hav-
ing a poor outcome at study start, patients were also
excluded who were malnourished (body mass index
[BMI] , 18.5 kg/m2), had metastatic solid tumors, were
receiving less or more than 3 treatments per week, or
were treated with a catheter at baseline.
Anonymized patient data were accessed through the
European Clinical Database, which has been described
elsewhere.11,12 All patients consented that their data may
be used for scientific research in anonymized form.
Lean tissue index (LTI) and fat tissue index (FTI) were
calculated as the ratio of the respective tissue masses divided
by the height in meters squared. The definition of the age-
and gender-dependent reference groups of LTI and FTI,
respectively, was based on an evaluation of 1,000 healthy in-
dividuals: ‘‘normal’’ LTI and FTI were defined as levels be-
tween the 10th and 90th percentile of the normal LTI or
FTI distribution, respectively, whereas ‘‘low’’ is defined as
under the 10th percentile and ‘‘high’’ as above the 90th
percentile of the respective normal distributions.13
LTI and FTI were evaluated at intervals defined according
to the network policy using the BCM (FMC),which is based
on multifrequency bioimpedance spectroscopy at 50
different frequencies ranging between 5 and 1,000 kHz.
BCM measures overhydration, total body water (in liters),
extracellular water (in liters), intracellular water (in liters),
fat tissue mass (in kilograms), lean tissue mass (in kilograms),
and body cell mass. BCM has been validated against the
following gold standard referencemethods: bromide dilution
for extracellular water, total body potassium for intracellular
water, deuteriumdilution for total bodywater, DXA for lean
tissue mass, 4 compartment modeling, air displacement
Figure 2. Patient selection. Body composition measurement
was conducted with the Body Composition Monitor (BCM;
FMC, Bad Homburg, Germany). BMI, body mass index;
ICD, International Classification of Diseases; RRT, renal
replacement therapy.
Table 1. Patient Characteristics at Baseline
List of Variables
General characteristics
Area (N)
West Europe 2,459
East Europe 4,922
Latin America and South Africa 846
Age (y; mean 6 SD) 61.46 6 14.65
Age groups (%)
$18 - ,57 y 33.27
$57 - ,67 y 27.15
$67 y 39.58
Gender (female, %) 36.38
Body composition
Dialysis post weight (kg; mean 6 SD) 71.93 6 15.05
BMI: body mass index
(kg/m2; mean 6 SD)
26.78 6 5.15
LTI: lean tissue index
(kg/m2; mean 6 SD)
13.10 6 2.84
LTI-reference groups (%)
Low LTI 42.68
Normal LTI 54.30
High LTI 3.03
FTI: fat tissue index (kg/m2; mean 6 SD) 12.76 6 6.01
FTI-reference groups (%)
Low FTI 7.80
Normal FTI 72.14
High FTI 3.03
Pre-dialysis overhydration
(L; mean 6 SD)
2.02 6 1.74
Post-dialysis overhydration
(L; mean 6 SD)
20.18 6 1.94
Comorbidities
Charlson Comorbidity Index (%)
2 46.36
3 15.24
4 21.16
$5 17.24
Diabetes (%) 32.88
Chronic ischemic heart disease (%) 13.57
Heart failure (%) 8.12
Arrhythmia (%) 8.64
Peripheral artery disease (%) 13.68
Stroke (%) 8.21
Cirrhosis (%) 0.82
Malignancies (%) 6.70
Respiratory diseases (%) 6.32
Laboratory values
Albumin (g/dL; mean 6 SD) 3.81 6 0.41
CRP (mg/L; median; interquartile range) 6.0 (2.47-14.45)
Hemoglobin (g/dL; mean 6 SD) 10.90 6 1.24
Creatinine pre (mg/dl; mean 6 SD) 7.10 6 3.99
Phosphate (mg/dL; mean 6 SD) 4.81 6 1.23
Total cholesterol (mg/dL; mean 6 SD) 174.34 6 44.07
Equilibrated Kt/V (mean 6 SD) 1.36 6 0.30
CRP, C-reactive protein; SD, standard deviation.
Details of patient numbers per country and of countries per
geographical region: West Europe 5 France (211), Italy (271),
Portugal (1,216), Spain (742), and the United Kingdom (19); East
Europe 5 Bosnia (219), Croatia (4), Czech Republic (421), Estonia
(8), Hungary (241), Poland (931), Romania (1,129), Russia (727),
Serbia (90), Slovakia (319), Slovenia (64), Sweden (4), and Turkey
(765); Latin America and South Africa 5 Chile (33), Colombia (797),
and South Africa (16).
MARCELLI ET AL74plethysmography, under water weighing for adipose tissue
mass, magnet resonance tomography for body cell mass
and an expert clinical assessment for overhydration.14
Statistical Analysis
The outcomes BMI, LTI, and FTIwere analyzed to eval-
uate the nutrition status of the patients. Descriptive analysis
was performed comparing current values for each patient
with their baseline values for each 1-month interval (delta
analysis). In cases without a measurement in the interval,
the value of the previous interval was used (last observation
carried forward).
To analyze differences between certain patient groups in
the development of BMI, LTI, and FTI, linear mixed
models were used. We applied an autoregressive process
of first order as covariance structure to consider the specific
structure of the repeated measurements in irregular inter-
vals. For each outcome (BMI, LTI, and FTI) a separate
mixed model with an adjustment for the three cardiovascu-
lar comorbidities chronic ischemic heart disease (Interna-
tional Classification of Diseases [ICD]-10 code I25), heart
failure (ICD-10 code I50), and peripheral artery diseases
(PAD; ICD-10 codes I70-I79) were fitted. In each model,
the time (in days) was included as covariate. In addition, the
factors gender, age (in tertiles: 18-56; 57-66; $67), dia-
betes, LTI- and FTI-reference groups (‘‘low,’’ ‘‘normal,’’
‘‘high’’) were included as main effects and as interactions
with time. The main effects show average differences in
the BC between certain subgroups. Interaction terms be-
tween the factors and the time are used to identify whether
the changes in BMI, FTI, and LTI differ in these subgroups
over time during the 2 years of follow-up.
BODY COMPOSITION CHANGES IN INCIDENT DIALYSIS PATIENTS 75All covariates were categorical and therefore
were included in the model as dummy variables. The cor-
responding reference categories are reported in the tables in
the Results section. Because of the high number of
covariates, Akaike information criterion (AIC) was used
to select covariates. AIC model selection balances between
the goodness of fit and the complexity of the model and can
therefore result in exclusion of some covariates that have a
low impact on the outcome. The analysis was conducted
with the statistical software SAS, version 9.4.Results
Patient selection is shown in Figure 2. After the selection
process, 8,227 patients of the original 49,846 patients were
recruited. Baseline characteristics are summarized in
Table 1. During the baseline period, patients had a median
of 4 (interquartile range: 2-5) BCM measurements. On
average, patients had a median of 7 (interquartile range:
3-14) BCM measurements after baseline, the last of which
was in mean 319 days after baseline. Figure 3 shows theBMIðtimeÞ 5 25:7810:00283time1

20:2720:0013time male
0 female
1
8<
:
0:2220:00093time $67years
1:0220:00043time ½57; 67Þyears
0 ,57years
1

0:86 diabetes
0 no diabetes
1

0:35 ischemic heart disease
0 no ischemic heart disease
1
8<
:
22:0610:00023time low LTI
2:7620:00153time high LTI
0 normal LTI
1
8<
:
24:9710:00053time low FTI
8:6920:00153time high FTI
0 normal FTI
[1]means of the delta analyses. In 2 years of follow-up, the
BMI increased by 0.6 kg/m2 (or 2.2%). This change
was mainly the result of an increase of 0.95 kg/m2 (7.4%)Figure 3. Delta analysis comparing current values of BMI,
LTI, and FTI with baseline values. BMI, body mass index;
FTI, fat tissue index; LTI, lean tissue index.in FTI and a decrease of 0.4 kg/m2 (3.1%) in LTI. These
changes in BMI, FTI, and LTI were significant for all inter-
vals (P , .001, paired t-tests).
The results of the linear mixed models for the outcomes
BMI, FTI, and LTI are summarized in Tables 2-4. All
covariates are listed with the appropriate reference
categories and the estimations for the specified groups,
the standard errors, and the P values. The results for the
time interactions are highlighted in the following section,
these being most relevant to the study aim.
Results for BMI
After AIC selection, the model for BMI no longer con-
tained PAD, heart failure, and the interaction term of dia-
betes and time (Table 2). Diabetes did not significantly
affect the development of BMI. BMI increased more for
females than for males, more for patients aged ,57 years
than for patients aged $67 years, and more for patients
with normal LTI and normal FTI than for patients with
high LTI and FTI at baseline. The model results can also
be summarized as shown in Formula 1.For example, the BMI for a female, aged between 57 and
66 years old, no diabetes, no ischemic heart disease, with
low LTI and high FTI is given by Formula 2.
BMIðtimeÞ525:7810:00283time11:0220:0004
3time22:0610:00023time18:6920:0015
3time533:4310:00113time
[2]
After 2 years of follow-up: BMIð730Þ533:431
0:00113730534:23
Results for FTI
After AIC selection, heart failure and the interaction
term between age and time were no longer in the
model. In this model, age did not appear to affect FTI
development as the interaction term between age and
time was not significant (Table 3). FTI increased more
MARCELLI ET AL76for females than for males, more for diabetic patients
than for non-diabetic patients, more for patients with
normal versus low baseline LTI, and more for patients
with low baseline FTI. The increase of FTI over the
time was smallest for patients with high FTI at baseline
(Formula 3)FTIðtimeÞ5 11:5310:0033time1

23:2920:0013time male
0 female
1
8<
:
2:44 $67 years
1:99 ½57; 67Þyears
0 ,57 years
1

0:7210:00093time diabetes
0 no diabetes
1

0:25 ischemic heart disease
0 no ischemic heart disease
1

0:15 PAD
0 no PAD
1
8<
:
0:8820:00063time low LTI
20:5010:00013time high LTI
0 normal LTI
1
8<
:
25:8010:0013time low FTI
9:2420:0023time high FTI
0 normal FTI
[3]For example, the FTI for a female, aged between 57
and 66 years old, no diabetes, no ischemic heart disease,
without PAD, with low LTI and high FTI is given by
Formula 4.LTIðtimeÞ5 13:9120:00023time1

2:8320:00023time male
0 female
1
8<
:
22:6920:00033time $67 years
21:2220:00023time ½57; 67Þ years
0 ,57 years
1

20:1620:00073time diabetes
0 no diabetes
1

20:11 heart failure
0 no heart failure
1

20:28 PAD
0 no PAD
1
8<
:
22:9810:00083time low LTI
3:1820:00193time high LTI
0 normal LTI
1
8<
:
0:6120:00063time low FTI
20:3210:00033time high FTI
0 normal FTI
[5]FTIðtimeÞ511:5310:0033time11:9910:8820:0006
3time19:2420:0023time524:3610:0013
3time
[4]
After 2 years of follow-up: FTIð730Þ523:541
0:00043730523:83Results for LTI
The same covariates were considered for the outcome
LTI. After AIC selection, the model no longer contained
chronic ischemic heart disease (Table 4). LTI decreased
more for males than for females, more for patients aged
$67 years than for patients aged ,57 years, more for dia-betic patients, and more for patients with high LTI or
low FTI at baseline. The smallest decrease in LTI was
observed for patients with low LTI or high FTI at baseline.
The model results can also be summarized by Formula 5.For example, the LTI for a female, aged between 57 and
66 years old, no diabetes, without heart failure, without
PAD, with low LTI and high FTI is given by Formula 6.
LTIðtimeÞ513:9120:0002  time21:2220:00023time
20:1122:9810:00083time20:3210:0003
3time59:2810:00073time
[6]
Table 2. Estimations of the Mixed Model for the Outcome BMI
Variable Reference Group Estimate Standard Error P Value
Intercept 25.7846 0.0938 ,.001
Time (d) 0.0028 0.0003 ,.001
Gender: male Female 20.2657 0.0815 .001
Age: (57; 67) Age , 57 1.0163 0.1001 ,.001
Age: $67 Age , 57 0.2179 0.0918 .018
Diabetes: yes No 0.8555 0.0696 ,.001
LTI-ref: low Normal 22.0646 0.0821 ,.001
LTI-ref: high Normal 2.7639 0.2308 ,.001
FTI-ref: low Normal 24.9664 0.1488 ,.001
FTI-ref: high Normal 8.6878 0.0995 ,.001
Ischemic heart disease: yes No 0.3452 0.0927 ,.001
Time 3 gender: male Female 20.0013 0.0002 ,.001
Time 3 age: (57;67) Age , 57 20.0004 0.0003 .167
Time 3 age: $67 Age , 57 20.0009 0.0003 .001
Time 3 LTI-ref: Low Normal 0.0002 0.0003 .519
Time 3 LTI-ref: High Normal 20.0015 0.0007 .031
Time 3 FTI-ref: Low Normal 0.0005 0.0005 .288
Time 3 FTI-ref: High Normal 20.0015 0.0003 ,.001
BMI, body mass index; FTI, fat tissue index; LTI, lean tissue index.
The result of the time interactions are highlighted in bold.
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73059:79
Discussion
This study, based on a large international cohort of
incident hemodialysis patients, reports a mean BMI in-
crease of 0.6 kg/m2 over 24 months from baseline. Pa-
tient nutritional status was monitored by bioimpedance
spectroscopy and revealed that changes in BMI were
associated with an increase of 0.95 kg/m2 in FTI and aTable 3. Estimations of the Linear Mixed Model for the Outcome
Variable Reference Group
Intercept
Time (d)
Gender: male Female
Age: (57; 67) Age , 57
Age: $67 Age , 57
Diabetes: yes No
LTI-ref: low Normal
LTI-ref: high Normal
FTI-ref: low Normal
FTI-ref: high Normal
Heart failure: yes No
PAD: yes No
Time 3 gender: male Female
Time 3 age: (57;67) Age , 57
Time 3 age: $67 Age , 57
Time 3 diabetes: yes No
Time 3 LTI-ref: low Normal
Time 3 LTI-ref: high Normal
Time 3 FTI-ref: low Normal
Time 3 FTI-ref: high Normal
FTI, fat tissue index; LTI, lean tissue index; PAD, peripheral artery disea
The result of the time interactions are highlighted in bold.decrease of 0.40 kg/m2 in LTI. These latter results
confirm trends reported by previous small-sized
studies,3,4,7 albeit the increase in fat body mass
reported by Pupim et al.3 during the first year on hemo-
dialysis was not associated with significant changes in
weight and BMI. This is the opposite of what was
reported by Mathew et al.,8 but it should be stressed that
anthropometry measurements are not only operator-
dependent but also subject to artifacts from fluid accumu-
lation. Therefore, it cannot be excluded that previousLTI
Estimate Standard Error P Value
13.9088 0.0419 ,.001
20.0002 0.0001 .114
2.8320 0.0362 ,.001
21.2249 0.0446 ,.001
22.6932 0.0409 ,.001
20.1644 0.0378 ,.001
22.9756 0.0366 ,.001
3.1785 0.1033 ,.001
0.6126 0.0668 ,.001
20.3244 0.0443 ,.001
20.1139 0.0424 .007
20.2830 0.0336 ,.001
20.0002 0.0001 .046
20.0002 0.0002 .277
20.0003 0.0001 .017
20.0007 0.0001 ,.001
0.0008 0.0001 ,.001
20.0019 0.0003 ,.001
20.0006 0.0002 .007
0.0003 0.0002 .034
se.
Table 4. Estimations of the Linear Mixed Model for the Outcome FTI
Variable Reference Group Estimate Standard Error P Value
Intercept 11.5251 0.0896 ,.001
Time (d) 0.0030 0.0003 ,.001
Gender: male Female 23.2891 0.0835 ,.001
Age: (57; 67) Age , 57 1.9908 0.0776 ,.001
Age: $67 Age , 57 2.4403 0.0718 ,.001
Diabetes: yes No 0.7201 0.0865 ,.001
LTI-ref: low Normal 0.8755 0.0841 ,.001
LTI-ref: high Normal 20.5028 0.2367 .034
FTI-ref: low Normal 25.8035 0.1528 ,.001
FTI-ref: high Normal 9.2372 0.1022 ,.001
Ischemic heart disease: yes No 0.2506 0.0887 .005
PAD: yes No 0.1486 0.0879 .091
Time 3 gender: male Female 20.0011 0.0003 ,.001
Time 3 diabetes: yes No 0.0009 0.0003 .001
Time 3 LTI-ref: low Normal 20.0006 0.0003 .020
Time 3 LTI-ref: high Normal 0.0001 0.0008 .938
Time 3 FTI-ref: Low Normal 0.0013 0.0005 .009
Time 3 FTI-ref: High Normal 20.0020 0.0003 ,.001
FTI, fat tissue index; LTI, lean tissue index; PAD, peripheral artery disease.
The result of the time interactions are highlighted in bold.
MARCELLI ET AL78results can be distorted by the hydration status, especially
considering that also DXA cannot provide diagnostic sep-
aration of muscle mass and fluid overload. In the present
study, the increase of fat and the decrease in lean body
mass was associated with an increased BMI already after
1 year (Fig. 3). This observation supports the theory3 that
fat mass may increase quickly during the first year of hemo-
dialysis and continue to increase slowly thereafter for
approximately 7 years.
An additional analysis was conducted to analyze whether
changes in the nutritional parameters differ in different re-
gions (West Europe [reference category], East Europe and
Latin America and South Africa). Here, geographical area
was included in the linear mixed models as main effect
and interactionwith the time. Significantly higher increases
in BMI (0.0008 kg/m2 per day; P value 5 .002) and FTI
(0.0011 kg/m2 per day; P value, .001) were found for pa-
tients from East Europe compared with patients fromWest
Europe. All other comparisons between the areas regarding
the development of BMI, LTI, and FTI were not
significant.
Regarding the development of fat mass (Table 3), FTI
increase was significantly lower for males compared with
females, whereas the presence of diabetes was associated
with a significantly higher increase of FTI over time. In
agreement with the study of Pupim et al.,3 patients with
the lowest baseline FTI showed the highest increase over
time. In addition, patients with high baseline LTI showed
the greater increase of fat tissue.
Regarding the loss of lean mass (Table 4), LTI decreased
more in elderly patients (age $67 years) and males than in
younger patients and females. It is known from previous
studies assessing total body potassium in normal subjects
that lean body mass peaks in the third and fourth decadeof life, followed by a steady decline with advancing
age.15,16 A more recent study17 in older adults based on hy-
drodensitometry evaluations showed a 2% decrease in fat-
free mass per decade in men but not in women, whereas
fat mass increased similarly in both genders (7.5% per
decade). It is known that the uremic state is associated
with several endocrine abnormalities including the axis hy-
pothalamus–pituitary gland–gonads regulation, growth
hormone and insulin growth factor regulation, and hor-
mone receptor interaction.18 The consequent hormonal
derangement is known as uremic hypogonadism,18 possibly
affects the accelerated loss of muscle mass in men.17,19
In our study, diabetes was also significantly associated
with a greater decrease in LTI, confirming previous reports
for older adults with type 2 diabetes not on renal replace-
ment treatment.5,20 Loss of lean tissue was higher in
patients with lower baseline FTI and higher baseline LTI.
One can speculate that if the energy reserve of fat is low,
lean tissue (muscle mass essentially) catabolism is then
facilitated. On the other hand, when the level of muscle
mass is already low, the option to have further loss is quite
limited.
Inflammation and metabolic acidosis cause wasting of
muscle mass through a ubiquitin-mediated process.21
Patients treated with a catheter 6 months after initiation
of RRTwere excluded from the study to ensure a homog-
enous well-treated population, ruling out catheter as an in-
flammatory source. Recovery of visceral proteins
(specifically albumin) after inflammatory events occurs
fairly quickly, but regeneration of lost somatic proteins, spe-
cifically muscle, is less well assured. Although inflammation
occurs in episodes in hemodialysis patients,22 patients who
have evidence of inflammation at 1 point in time are more
likely to experience inflammation later. In an additional
BODY COMPOSITION CHANGES IN INCIDENT DIALYSIS PATIENTS 79analysis, we also considered the presence of a microinflam-
matory process by means of a C-reactive protein higher
than 10 mg/dL, but we did not find any significant associ-
ation, possibly due to the paucity of data points (data not
shown).
Non-CKD patients with other chronic diseases (e.g.,
breast cancer) frequently gain weight after diagnosis that
is accompanied by either no change in lean tissue or with
a loss of lean tissue. This pattern is defined as sarcopenic
obesity and, like the pattern in dialysis patients, is associated
with a long history of corticosteroid use, hypopituitarism,
hypogonadism, and prolonged physical inactivity.23,24
This study has limitations inherent in any observation
study, particularly that causality cannot be assumed. It is
well known that physical exercise facilitates development
of muscle and may blunt the negative impact of inflamma-
tion onmuscle, but a surrogate, such as muscle strength, was
not evaluated in this study. Also, no direct comparison with
a healthy population matched for age and gender was done.
However, our previous study reported that as much as 47%
of almost 38,000 prevalent hemodialysis patients studied
had LTI lower than the 10th percentile of an age- and
gender-matched healthy population.25 Diet changes may
also affect the course of LTI and FTI changes, but the
network neither prescribes diets nor were there adequate
nPNA data available to facilitate investigation of this aspect.
Another limitation was our assumption that the decrease in
LTI was due to loss of muscle mass. However, it is also
possible that LTI loss may be affected by loss of bone, organ,
or connective tissue mass. Unfortunately, reliable data for
residual renal function and for eGFR at time of initiation
were not available. However, as baseline was defined at
6 months after initiation of RRT, residual renal function
can be assumed to be negligible. Strengths of the study lie
in the prospective collection of data, the homogenous prac-
tice in all clinics, the reliability and frequency of BC mea-
surements, the large international cohort of incident
patients, and the statistical methodology applied versus pre-
vious studies. The level of homogeneity of hemodialysis
practice in these clinics was high due to the clinics
belonging to the same network and thus sharing a common
set of medical and process targets, standard operating proce-
dures, and identical hemodialysis equipment/disposables.
This was verified by a quality control tool that detects
deviations and benchmarks outcome.26
After admission to hemodialysis, patients generally expe-
rience an improvement in appetite and general well-be-
ing.27 This study reports an increase in weight in incident
hemodialysis patients during 2 years of follow-up that is
mainly the result of a significant increase in FTI. This was
accompanied by a parallel, albeit of small magnitude,
decrease in LTI. A recent retrospective study of 37,345
prevalent hemodialysis patients addressing the association
between BC and survival found mortality was lowest
with both LTI and FTI in the 10th to 90th percentile (refer-ence group) and significantly higher at the lower LTI and
FTI extreme.25 Interestingly, the results of our longitudinal
study support the hypothesis generated in that cross-
sectional study25 of a possible protective effect of high
FTI in patients with low LTI. Because malnutrition, LTI,
and FTI are recognized important predictors of outcome
in hemodialysis patients, incident patients should be closely
monitored from the initiation of dialysis. Bioimpedance
spectroscopy offers clinicians a convenient method to assess
both fluid status and BC changes. The findings of this study
deserve further investigation including aspects of physical
exercise and muscle strength to address BC changes in inci-
dent dialysis patients in a more comprehensive manner.Practical Application
In the months after start of dialysis therapy, BMI
increased, FTI increased, and LTI decreased in this cohort
of 8,227 incident hemodialysis patients. Some patient char-
acteristics were associated with higher risk for having/
developing malnutrition. The magnitude of the problem
supports regular monitoring of all kidney disease patients
in terms of BC, at least from time of admission to dialysis.References
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